Literature DB >> 3182096

Ciprofloxacin in combination with metronidazole.

R Werk1, L Schneider.   

Abstract

Ciprofloxacin has a reduced activity against anaerobic pathogens. Therefore, a combination of ciprofloxacin with an antimicrobial agent active against anaerobes, such as metronidazole, seems to be interesting for the treatment of mixed aerobic/anaerobic infections. High metronidazole concentrations (10 mg/l or 40 mg/l) neither affected the bactericidal efficacy of ciprofloxacin on aerobic pathogens, such as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Enterococcus faecalis, nor on the anaerobic pathogens Clostridium perfringens and Clostridium difficile, as demonstrated by kill-kinetic curves. The same high concentrations, as well as lower therapeutically achievable concentration (2 mg/l or 5 mg/l) of metronidazole in combination with ciprofloxacin were slightly more potent for the tested clostridia than ciprofloxacin or metronidazole alone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182096     DOI: 10.1007/bf01650774

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  3 in total

Review 1.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

2.  Investigations into the mechanism of action of the antibacterial agent norfloxacin.

Authors:  G C Crumplin; M Kenwright; T Hirst
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

3.  Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth.

Authors:  H J Zeiler
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

  3 in total
  3 in total

1.  Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.

Authors:  M Boeckh; H Lode; K M Deppermann; S Grineisen; F Shokry; R Held; K Wernicke; P Koeppe; J Wagner; C Krasemann
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

Review 2.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

3.  Metronidazole and ciprofloxacin differentially affect chronic unpredictable mild stress-induced changes in the colon, cecum and ileum microbiota.

Authors:  Chen Meng; Chen Dong; Hong Liu
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-09       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.